Biological Products, (No Diagnostic Substances)·PL VENLO
Prospectuses & Registrations
19 shown
Filed
Form
Description
5/30/24
S-8
S-8
→
5/5/17
S-8
S-8
→
4/2/15
S-8
S-8
→
11/17/11
S-8
S-8
→
9/25/09
424B5
FINAL PROSPECTUS SUPPLEMENT
→
9/23/09
424B5
PROSPECTUS SUPPLEMENT
→
↓
Ownership
40 shown
Filed
Form
Description
11/8/24
SC 13G
SEC SCHEDULE 13G
→
11/7/24
SC 13G
SC 13G
→
10/21/24
SC 13G
SC 13G
→
2/9/24
SC 13G/A
SEC SCHEDULE 13G
→
1/23/24
SC 13G/A
SC 13G/A
→
12/6/23
SC 13G/A
SEC SCHEDULE 13G
→
↓
Other Filings
40 shown
Filed
Form
Description
2/10/26
SCHEDULE 13G/A
SCHEDULE 13G/A
→
2/6/26
SCHEDULE 13G
SCHEDULE 13G
→
1/9/26
25-NSE/A
25-NSE/A
→
1/8/26
25-NSE
25-NSE
→
11/12/25
SCHEDULE 13G/A
SCHEDULE 13G/A
→
8/15/25
144
144
→
↓
Filing History(495 filings)
TypeDateAccessionPeriodSize
SCHEDULE 13G/A
Feb 10, 2026
0000902219-26-000087
—
16.9 KB
SCHEDULE 13G
Feb 6, 2026
0002012383-26-000897
—
11.2 KB
6-K
Feb 6, 2026
0001015820-26-0000036-K
Dec 31, 2025
472.0 KB
25-NSE/A
Jan 9, 2026
0000876661-26-000033
—
3.3 KB
25-NSE
Jan 8, 2026
0000876661-26-000016
—
4.5 KB
6-K
Dec 22, 2025
0001015820-25-0000776-K
Dec 31, 2025
149.0 KB
SCHEDULE 13G/A
Nov 12, 2025
0000902219-25-000383
—
16.9 KB
6-K
Nov 6, 2025
0001015820-25-0000746-K
Sep 30, 2025
1.2 MB
6-K
Nov 6, 2025
0001015820-25-0000726-K
Sep 30, 2025
712.1 KB
6-K
Sep 2, 2025
0001015820-25-0000626-K
Aug 31, 2025
218.6 KB
6-K
Aug 21, 2025
0001015820-25-0000576-K
Jun 30, 2025
1.2 MB
144
Aug 15, 2025
0001015820-25-000054
—
6.2 KB
144
Aug 15, 2025
0001950047-25-005910
—
7.9 KB
144
Aug 14, 2025
0001950047-25-005859
—
7.0 KB
144
Aug 13, 2025
0001950047-25-005796
—
5.1 KB
SCHEDULE 13G/A
Aug 12, 2025
0000902219-25-000274
—
16.7 KB
6-K
Aug 7, 2025
0001015820-25-0000496-K
Jun 30, 2025
486.1 KB
6-K
Jun 30, 2025
0001015820-25-0000446-K
Jun 30, 2025
142.4 KB
SD
Jun 2, 2025
0001015820-25-000040SD
—
42.2 KB
SCHEDULE 13G/A
May 14, 2025
0000912938-25-000062
—
6.6 KB
6-K
May 13, 2025
0001015820-25-0000376-K
Mar 31, 2025
962.4 KB
6-K
May 9, 2025
0001015820-25-0000346-K
Mar 31, 2025
383.4 KB
6-K
Apr 9, 2025
0001015820-25-0000306-K
Apr 30, 2025
142.2 KB
IRANNOTICE
Mar 31, 2025
0001015820-25-000028IRANNOTICE
—
99.5 KB
20-F
Mar 31, 2025
0001015820-25-00002720-F
Dec 31, 2024
47.5 MB
25 filings shown
QIAGEN N.V. — SlamSEC
V. is a German-founded multinational provider of sample and assay technologies for molecular diagnostics, applied testing, academic research, and pharmaceutical research.